A novel vaccine platform using glucan particles for induction of protective responses against Francisella tularensis and other pathogens

被引:19
作者
Abraham, A. [1 ]
Ostroff, G. [1 ]
Levitz, S. M. [1 ]
Oyston, P. C. F. [2 ]
机构
[1] Univ Massachusetts, Sch Med, Worcester, MA USA
[2] Def Sci & Technol Lab, CBR Div, Salisbury, Wilts, England
基金
美国国家卫生研究院;
关键词
beta-glucans; fungal; tularemia; vaccine; CD4(+) T-CELLS; BETA-GLUCAN; PNEUMONIC TULAREMIA; TRAINED IMMUNITY; PROTEIN; ACTIVATION; ADJUVANT; ANTIBODY; DECTIN-1; ANTIGEN;
D O I
10.1111/cei.13356
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vaccines are considered the bedrock of preventive medicine. However, for many pathogens, it has been challenging to develop vaccines that stimulate protective, long-lasting immunity. We have developed a novel approach using beta-1,3-D-glucans (BGs), natural polysaccharides abundantly present in fungal cell walls, as a biomaterial platform for vaccine delivery. BGs simultaneously provide for receptor-targeted antigen delivery to specialized antigen-presenting cells together with adjuvant properties to stimulate antigen-specific and trained non-specific immune responses. This review focuses on various approaches of using BG particles (GPs) to develop bacterial and fungal vaccine candidates. A special case history for the development of an effective GP tularaemia vaccine candidate is highlighted.
引用
收藏
页码:143 / 152
页数:10
相关论文
共 74 条
[1]   Zymosan A enhances humoral immune responses to soluble protein in chickens [J].
Abou Elazab, Mohamed Fahmy ;
Inoue, Yoshiaki ;
Kamei, Hisakazu ;
Horiuchi, Hiroyuki ;
Furusawa, Shuichi .
JOURNAL OF VETERINARY MEDICAL SCIENCE, 2017, 79 (08) :1335-1341
[2]  
Agarwal S, 2011, MBIO, V2
[3]   Zymosan Enhances the Mucosal Adjuvant Activity of Poly(I:C) in a Nasal Influenza Vaccine [J].
Ainai, Akira ;
Ichinohe, Takeshi ;
Tamura, Shin-ichi ;
Kurata, Takeshi ;
Sata, Tetsutaro ;
Tashiro, Masato ;
Hasegawa, Hideki .
JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (03) :476-484
[4]   Vaccines based on whole recombinant Saccharomyces cerevisiae cells [J].
Ardiani, Andressa ;
Higgins, Jack P. ;
Hodge, James W. .
FEMS YEAST RESEARCH, 2010, 10 (08) :1060-1069
[5]   Microparticulate β-glucan vaccine conjugates phagocytized by dendritic cells activate both naive CD4 and CD8 T cells in vitro [J].
Berner, Vanessa K. ;
duPre, Sally A. ;
Redelman, Doug ;
Hunter, Kenneth W. .
CELLULAR IMMUNOLOGY, 2015, 298 (1-2) :104-114
[6]   (1->3)-beta-D-glucans as biological response modifiers: A review of structure-functional activity relationships [J].
Bohn, JA ;
BeMiller, JN .
CARBOHYDRATE POLYMERS, 1995, 28 (01) :3-14
[7]   Francisella tularensis Susceptibility toAntibiotics: A Comprehensive Review of the Data Obtained In vitro and in Animal Models [J].
Caspar, Yvan ;
Maurin, Max .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
[8]   mTOR- and HIF-1α-mediated aerobic glycolysis as metabolic basis for trained immunity [J].
Cheng, Shih-Chin ;
Quintin, Jessica ;
Cramer, Robert A. ;
Shepardson, Kelly M. ;
Saeed, Sadia ;
Kumar, Vinod ;
Giamarellos-Bourboulis, Evangelos J. ;
Martens, Joost H. A. ;
Rao, Nagesha Appukudige ;
Aghajanirefah, Ali ;
Manjeri, Ganesh R. ;
Li, Yang ;
Ifrim, Daniela C. ;
Arts, Rob J. W. ;
van der Meer, Brian M. J. W. ;
Deen, Peter M. T. ;
Logie, Colin ;
O'Neill, Luke A. ;
Willems, Peter ;
van de Veerdonk, Frank L. ;
van der Meer, Jos W. M. ;
Ng, Aylwin ;
Joosten, Leo A. B. ;
Wijmenga, Cisca ;
Stunnenberg, Hendrik G. ;
Xavier, Ramnik J. ;
Netea, Mihai G. .
SCIENCE, 2014, 345 (6204) :1579-+
[9]   Orally administered β-glucans enhance anti-tumor effects of monoclonal antibodies [J].
Cheung, NKV ;
Modak, S ;
Vickers, A ;
Knuckles, B .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2002, 51 (10) :557-564
[10]   Whole glucan particles as a vaccine against systemic coccidioidomycosis [J].
Clemons, Karl V. ;
Antonysamy, Mary A. ;
Danielson, Michael E. ;
Michel, Kyle S. ;
Martinez, Marife ;
Chen, Vicky ;
Stevens, David A. .
JOURNAL OF MEDICAL MICROBIOLOGY, 2015, 64 :1237-1243